CT-179 is an OLIG2 inhibitor with brain permeability and oral availability. CT-179 inhibits its transcriptional activity by disrupting OLIG2 dimerization, phosphorylation, and DNA binding. CT-179 induces G2/M phase arrest, promotes apoptosis, and differentiation in tumor cells. CT-179 can be used for cancer research[1].
Molekulargewicht:
397.30
Reinheit:
99.61
CAS Nummer:
[1996636-69-1]
Formel:
C17H22Cl2N6O
Target-Kategorie:
Apoptosis,OLIG2
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten